AAS
NVO

Ameritas Advisory Services’s Novo Nordisk NVO Stock Holding History

Ameritas Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Buy
48,394
+27,209
+128% +$1.17M 0.05% 333
2026
Q1 		$779K Buy
21,185
+6,594
+45% +$312K 0.03% 449
2025
Q4 		$742K Sell
14,591
-4,791
-25% -$245K 0.03% 442
2025
Q3 		$1.08M Buy
19,382
+14,405
+289% +$843K 0.07% 238
2025
Q2 		$344K Buy
4,977
+1,449
+41% +$98.6K 0.02% 595
2025
Q1 		$273K Sell
3,528
-7,472
-68% -$617K 0.01% 728
2024
Q4 		$946K Buy
11,000
+9,012
+453% +$975K 0.03% 430
2024
Q3 		$237K Sell
1,988
-8,927
-82% -$1.19M 0.01% 755
2024
Q2 		$1.56M Sell
10,915
-307
-3% -$40.7K 0.06% 306
2024
Q1 		$1.4M Buy
11,222
+7,284
+185% +$867K 0.06% 307
2023
Q4 		$440K Sell
3,938
-7,175
-65% -$710K 0.02% 460
2023
Q3 		$1.1M Buy
11,113
+2,493
+29% +$220K 0.05% 321
2023
Q2 		$677K Buy
8,620
+66
+0.8% +$5.39K 0.09% 235
2023
Q1 		$684K Buy
+8,554
New +$607K 0.03% 401

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ameritas Advisory Services's NVO Position: Q2 2026 in Review

Ameritas Advisory Services increased its Novo Nordisk (NVO) stake by 128% in Q2 2026, buying an estimated $1.17M and bringing the position to 48,394 shares worth $2.32M. The position accounts for 0.05% of the portfolio, ranked #333.

Ameritas Advisory Services first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Ameritas Advisory Services held 48,394 shares of Novo Nordisk worth $2.32M as of Q2 2026.
  • Ameritas Advisory Services bought 27,209 Novo Nordisk shares in Q2 2026, an estimated $1.17M.
  • Novo Nordisk made up 0.05% of Ameritas Advisory Services's portfolio in Q2 2026, its #333 holding.
  • Ameritas Advisory Services first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.